Related Experiment Video
Updated: Jul 1, 2026
12:24
Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Inhibitors targeting two-component signal transduction.
Takafumi Watanabe1, Ario Okada, Yasuhiro Gotoh
1Department of Bioscience, Graduate School of Agriculture, Kinki University, 3327-204 Nakamachi, Nara 631-8505, Japan.
Advances in Experimental Medicine and Biology
|September 17, 2008
Summary
Novel drug discovery systems target essential bacterial two-component signal transduction systems (TCS) for new antibacterial agents. Researchers reviewed TCS inhibitors and developed new methods to find YycG/YycF system inhibitors.
Area of Science:
- Microbiology
- Pharmacology
- Drug Discovery
Background:
- Two-component signal transduction systems (TCS) are crucial for bacterial survival and represent promising targets for novel antibacterial therapies.
- The YycG/YycF system is an essential TCS in bacteria, making it a high-priority target for drug development.
- Inhibitors of TCS have shown potential as antibacterial agents, necessitating continued research into their discovery and development.
Purpose of the Study:
- To review the progress in developing two-component signal transduction system (TCS) inhibitors over the last decade.
- To introduce innovative drug discovery systems for identifying inhibitors of the YycG/YycF system.
- To facilitate the development of a new class of antibacterial agents targeting essential bacterial TCS.
Main Methods:
- Literature review of TCS inhibitors developed in the past 10 years.
- Development and application of novel drug discovery systems.
- Focus on isolating inhibitors specific to the YycG/YycF two-component system.
Main Results:
- A comprehensive overview of existing TCS inhibitors was compiled.
- New drug discovery platforms were established for identifying YycG/YycF inhibitors.
- The study lays the groundwork for discovering novel antibacterial compounds.
Conclusions:
- Two-component signal transduction systems are viable targets for antibacterial drug development.
- Novel drug discovery systems offer a promising approach to identify inhibitors of essential bacterial TCS like YycG/YycF.
- Continued research in this area is vital for combating bacterial infections with new therapeutic agents.
More Related Videos
Related Concept Videos
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...